| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 58.403 | 73.210 | 69.173 | 77.580 | 83.554 | 79.455 | 119.486 | 108.661 | 105.962 | 129.414 |
| Total Income - EUR | 58.620 | 73.450 | 69.177 | 77.580 | 83.554 | 80.029 | 119.486 | 108.661 | 105.962 | 129.414 |
| Total Expenses - EUR | 12.141 | 7.683 | 5.262 | 7.963 | 7.207 | 7.918 | 9.002 | 10.544 | 11.257 | 12.157 |
| Gross Profit/Loss - EUR | 46.479 | 65.767 | 63.915 | 69.617 | 76.347 | 72.111 | 110.485 | 98.117 | 94.705 | 117.257 |
| Net Profit/Loss - EUR | 44.721 | 63.563 | 63.223 | 68.842 | 75.511 | 71.369 | 109.313 | 97.052 | 93.667 | 113.452 |
| Employees | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medfiv-Ba Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.547 | 9.778 | 10.383 | 9.164 | 8.512 | 8.968 | 6.985 | 4.364 | 2.721 | 1.241 |
| Current Assets | 83.241 | 55.001 | 53.996 | 64.140 | 71.474 | 66.627 | 140.929 | 106.668 | 115.122 | 144.635 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Receivables | 9.577 | 2.189 | 7.585 | 6.495 | 1.856 | 6.990 | 88.700 | 78.122 | 98.405 | 84.544 |
| Cash | 73.663 | 52.812 | 46.410 | 57.645 | 69.618 | 59.637 | 52.229 | 28.546 | 16.717 | 60.091 |
| Shareholders Funds | 87.238 | 64.181 | 63.830 | 72.706 | 79.301 | 71.943 | 109.874 | 97.614 | 94.228 | 114.010 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 549 | 597 | 548 | 598 | 685 | 3.653 | 38.039 | 13.417 | 23.616 | 31.866 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medfiv-Ba Srl